ビジネス · 2016/6/101 分で読めます
Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public.